Renal Denervation in Refractory Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 106 participants.

Also called NCT01560312

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01560312
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01560312. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Denervation in Refractory Hypertension
Acronym
PRAGUE-15
Condition
Hypertension
Condition
Resistant to Conventional Therapy
Intervention (Device)
Renal denervation (Symplicity® Catheter System™)
Lead sponsor
Charles University, Czech Republic (class: other)
Collaborator
General University Hospital, Prague (class: other)
Collaborator
University Hospital Olomouc (class: other)
Collaborator
Cardiocenter Podlesí, Trinec, Czech Republic (class: not stated)

Record details

Record id
cardio:ct-nct01560312
Content hash
60459f37eb32fdacb42792cf9830d076cbded8ed41ffd2147f564671b448d50a